A new study led by researchers from the Xinjiang Institute of Ecology and Geography of the Chinese Academy of Sciences has ...

Novo Nordisk’s once-weekly Sogroya (somapacitan) has proved to be non-inferior to the once-daily growth hormone Norditropin ...

Novo Nordisk reports phase 3 data showing weekly Sogroya matched or outperformed daily hormone therapy in multiple pediatric ...

Novo Nordisk reported positive data from a late-stage trial of its once-weekly Sogroya treatment for children with growth disorders.

According to Little Umbrella's research, the top three health concerns among parents are immunity, height growth, and brain ...

Growth patterns during a child's first two years of life may shape pubertal growth and adult height, but have little effect ...

Fastly posted 8% y/y growth and raised FY25 outlook, trading at ~2x forward sales amid margin and retention risks. Learn why ...

Children’s growth in the first two years of life significantly influences their pubertal growth and adult height, but not ...

Corteva Inc (CTVA) reports a robust 15% increase in EBITDA and significant margin improvements, while navigating currency ...

The research, published in Nature Human Behavior, analyzed MRI scans from over 1,000 children to map how different brain ...

The global agritech market is experiencing rapid growth due to rise in emphasis on food productivity and increase in demand ...

RPM International, a $14B global company and Dividend King, leverages strong financials and a low payout ratio to sustain ...